HSBC Holdings’s Dr. Reddy's Laboratories RDY Stock Holding History

HSBC Holdings’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-21,500	Closed	-$339K	–	3222
2024 Q4	$339K	Buy	21,500 +4,000	+23%	+$60.1K	﹤0.01%	2421
2024 Q3	$278K	Sell	17,500 -2,500	-13%	-$40.2K	﹤0.01%	2403
2024 Q2	$302K	Hold	20,000	–	–	﹤0.01%	2271
2024 Q1	$293K	Buy	+20,000	New	+$292K	﹤0.01%	2448
2023 Q4	–	Sell	-37,500	Closed	-$495K	–	2884
2023 Q3	$495K	Buy	+37,500	New	+$507K	﹤0.01%	1991
2015 Q3	–	Sell	-7,925	Closed	-$88K	–	2123
2015 Q2	$88K	Buy	+7,925	New	+$87.5K	﹤0.01%	1935

Other funds holding RDY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

AIM

Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

HSBC Holdings's RDY Position: Q1 2026 in Review

HSBC Holdings held its Dr. Reddy's Laboratories (RDY) position steady in Q1 2026 at 78,293 shares worth $1.08M. The position accounts for ﹤0.01% of the portfolio, ranked #1828.

HSBC Holdings first reported a position in RDY in Q2 2013 and has held it in 52 quarters since. The position peaked at $28.8M in Q4 2016. 248 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

HSBC Holdings held 78,293 shares of Dr. Reddy's Laboratories worth $1.08M as of Q1 2026.
HSBC Holdings left its Dr. Reddy's Laboratories share count unchanged in Q1 2026.
Dr. Reddy's Laboratories made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #1828 holding.
HSBC Holdings first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 52 quarters since.
HSBC Holdings's Dr. Reddy's Laboratories position peaked at $28.8M in Q4 2016.
248 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.